Summary: Aminoglycoside antibiotics, used to treat bacterial infections by interfering with proofreading during protein synthesis, cause sensorineural hearing loss in genetically susceptible individuals. The only aminoglycoside-hypersensitivity mutations which have been described in humans are in the mitochondrial 12S rRNA gene, potentially allowing increased antibiotic binding to mitochondrial ribosomes. To identify additional predisposing mutations, a yeast model system was used to isolate genes which interact with or bypass the effects of aminoglycoside antibiotics. A novel yeast gene was isolated which, in high copy, confers neomycin resistance to yeast transformants. The neomycin-resistance 1 gene (NEO1) encodes a potential 1151 aa integral membrane protein, most homologous to the yeast DRS2 gene product, a Ca2+-ATPase involved in cytoplasmic ribosome assembly. The N-terminus of Neo1p is partially homologous to abrin A-chain, another protein which interacts with cytoplasmic ribosomes. Mutagenesis experiments demonstrate that the NEO1 product is essential for vegetative growth and that the drug-resistance phenotype requires ATPase function.
BacinoC.,
PrezantT. R.,
BuX.,
FournierP.,
Fischel-GhodsianN.1995; Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafness. Pharmacogenetics165–172
CarlsonM.,
BotsteinD.1982; Two differentially regulated mRNAs with different 5’ ends encode secreted with intracellular forms of yeast invertase. Cell 28:145–154
ChaddockJ. A.,
LordJ. M.,
HartleyM. R.,
RobertsL. M.1994; Pokeweed antiviral protein (PAP) mutations which permit E. coli growth do not eliminate catalytic activity towards prokaryotic ribosomes. Nucleic Acids Res 22:1536–1540
DayhoffM. O.,
SchwartzR. M.,
OrcuttB. C.1978; A model of evolutionary change in proteins. In Atlas of Protein Sequence and Structure5 suppl. 3 pp. 89–99DayhoffM. O.
Edited by Washington, DC: National Biomedical Research Foundation.;
EndoY.,
MitsuiK.,
MotizukiM.,
TsurugiK.1987; The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins. J Biol Chem 262:5908–5912
GaretzS. L.,
RheeD. J.,
SchachtJ.1994; Sulfhydryl com¬ pounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro.
. Hearing Res 77:75–80
HornigH.,
WoolleyP.,
LuhrmanR.1987; Decoding at the ribosomal A site: antibiotics, misreading and energy of aminoacyl- tRNA binding. Biochimie 69:803–818
HutchinT.,
HaworthI.,
HigashiK.,
Fischel-GhodsianN.,
StonekingM.,
SahaN.,
ArnosC.,
CortopassiG.1993; A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucleic Acids Res 21:4174–4179
KimY.,
RobertusJ. D.1992; Analysis of several key active site residues of ricin A chain by mutagenesis and X-ray crystallography. Protein Eng 5:775–779
LeppertG.,
McDevittR.,
FalcoS. C.,
FickeM. B.,
GolinJ.1990; Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces.
. Genetics 125:13–20
LiM.,
TzagoloffA.,
Underbrink-LyonK.,
MartinN. C.1982; Identification of the paromomycin-resistance mutation in the 15S rRNA gene of yeast mitochondria. J Biol Chem 257:5921–5928
MarboisB. N.,
HsuA.,
PillaiR.,
ColicelliJ.,
ClarkeC. F.1994; Cloning of a rat cDNA encoding dihydroxypolyprenylbenzoate methyltransferase by functional complementation of a Saccharomyces cerevisiae mutant deficient in ubiquinone biosynthesis. Gene 138:213–217
PrezantT. R.,
AgapianJ. V.,
BohlmanM. C.1993; Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet 4:289–294
RipmasterT. L.,
VaughnG. P.,
WoolfordJ. L.1993; DRS1 to DRS7, novel genes required for ribosome assembly and function in Saccharomyces cerevisiae.
. Mol Cell Biol 13:7901–7912
RudolphH. K.,
AntebiA.,
FinkG. R.,
BuckleyC. M.,
DormanT. E.,
LeVitreJ.,
DavidowL. S.,
MaoJ. -l.,
MoirD. T.1989; The yeast secretory pathway is perturbed by mutations in PMR1, a member of a Ca2+ ATPase family. Cell 58:133–145
SaikiR. K.,
GelfandD. H.,
StoffelS.,
ScharfS. J.,
HiguchiR.,
HornG. T.,
MullisK. B.1988; Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
SandbakenM. G.,
LupisellaJ. A.,
DiDomenicoB.,
ChakraburttyK.1990; Protein synthesis in yeast. Structural and functional analysis of the gene encoding elongation factor 3. J Biol Chem 265:15838–15844
SandeM. A.,
MandellG. L.1990; Antimicrobial agents. In The Pharmacological Basis of Therapeutics,, 8th edn. pp. 1098–1116GilmanA. G.,
RailT. W.,
NiesA. S.,
TaylorP.
Edited by Elmsford, NY: Pergamon Press.;
SerranoR.1991; Transport across yeast vacuolar and plasma membranes. In The Molecular and Cellular Biology of the Yeast Saccharomyces: Genome Dynamics, Protein Synthesis, and Energetics pp. 523–586 Cold Spring Harbor, NY:: Cold Spring Harbor Laboratory.;
SikorskiR. S.,
HieterP.1989; A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
. Genetics 122:19–27
UlaszewskiS.,
BalziE.,
GoffeauA.1987; Genetic and molecular mapping of the pma1 mutation conferring vanadate resistance to the plasma membrane ATPase from Saccharomyces cerevisiae.
. Mol Gen Genet 207:38–46
WoodK. A.,
LordJ. M.,
WawrzynczakE. J.,
PiatakM.1991; Preproabrin: genomic cloning, characterisation and the expression of the A-chain in Escherichia coli.
. Eur J Biochem 198:723–732